Press Releases


2018 | 2017 | 2016 | 2015
E-mail Alerts Receive E-mail Alerts | RSS RSS Feeds
Keyword Search
 
DateTitle 
11/01/18Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific DiscoveryPrinter Friendly Version
10/30/18Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor ProfilingPrinter Friendly Version
10/23/18Illumina Reports Financial Results for Third Quarter of Fiscal Year 2018Printer Friendly Version
10/09/18Illumina to Announce Third Quarter 2018 Financial Results on Tuesday, October 23, 2018Printer Friendly Version
09/28/18Illumina Announces Conversion Period for 0% Convertible Senior Notes due 2019 and 0.5% Convertible Senior Notes due 2021Printer Friendly Version
08/30/18Illumina to Webcast Upcoming Investor Conference PresentationPrinter Friendly Version
08/27/18Illumina Receives Approval of MiSeq™Dx System in ChinaPrinter Friendly Version
08/16/18Illumina Announces Pricing of Convertible Senior NotesPrinter Friendly Version
08/15/18Illumina to Offer $650 Million Convertible Senior NotesPrinter Friendly Version
07/30/18Illumina Reports Financial Results for Second Quarter of Fiscal Year 2018Printer Friendly Version
07/10/18Illumina to Announce Second Quarter 2018 Financial Results on Monday, July 30, 2018Printer Friendly Version
05/29/18Illumina to Webcast Upcoming Investor Conference PresentationsPrinter Friendly Version
05/15/18Illumina Acquires Edico Genome to Accelerate Genomic Data AnalysisPrinter Friendly Version
05/02/18Illumina to Webcast Upcoming Investor Conference PresentationPrinter Friendly Version
04/24/18Illumina Reports Financial Results for First Quarter of Fiscal Year 2018Printer Friendly Version
04/13/18Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology ImmunotherapiesPrinter Friendly Version
04/10/18Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion DiagnosticsPrinter Friendly Version
04/10/18Illumina to Announce First Quarter 2018 Financial Results on Tuesday, April 24, 2018Printer Friendly Version
03/12/18Illumina Names Dr. Phil Febbo Chief Medical OfficerPrinter Friendly Version
02/27/18Illumina to Webcast Upcoming Investor Conference PresentationPrinter Friendly Version
01/30/18Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017Printer Friendly Version
01/26/18Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.Printer Friendly Version
01/16/18Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018Printer Friendly Version
01/08/18Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq TechnologyPrinter Friendly Version
01/08/18Illumina Launches iSeq 100 Sequencing SystemPrinter Friendly Version
01/04/18Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA ApprovalPrinter Friendly Version